MARK MCKINLEY: Open Payments
NPI 1811474216 · FORT BRAGG, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $58 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $364 |
| Janssen Biotech, Inc. | 3 | $73 |
| QOL Medical, LLC | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 4 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Braintree Laboratories, Inc. | 1 | $18 |
Products named: SKYRIZI, RINVOQ, TREMFYA, Sucraid, OCALIVA, VOQUEZNA, EOHILIA, VIBERZI.
Industry payments across NC — which companies pay providers there.
